Nevada Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 5 (62% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 3,131
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 76.72%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 425
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 74.19%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 22.42% 24.47%
White, Hispanic/Latino Patients 43.82% 48.24%
Black/African American, Non-Hispanic/Latino Patients 11.59% 10.82%
Black/African American, Hispanic/Latino Patients 0.10% 0.24%
Asian Patients3 6.23% 2.35%
American Indian/Alaska Native Patients3 0.70% 0.47%
Native Hawaiian/Other Pacific Islander Patients3 1.82% 0.71%
Patients with More than one race3 8.11% 4.71%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.50% 2.82%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.35% 0.24%
Unreported/Refused to Report Race and Ethnicity 3.35% 4.94%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 118
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 70.48%
COVID-19 Immunization Series Completed 324
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 68.06%
COVID-19 Immunization Series Additional 9
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 44.44%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 26.27% 28.40% 55.56%
White, Hispanic/Latino Patients 22.88% 18.52% 11.11%
Black/African American, Non-Hispanic/Latino Patients 16.95% 10.19% 11.11%
Black/African American, Hispanic/Latino Patients 0.00% 0.31% 0.00%
Asian Patients3 0.85% 4.01% 0.00%
American Indian/Alaska Native Patients3 0.00% 1.54% 11.11%
Native Hawaiian/Other Pacific Islander Patients3 0.85% 0.62% 0.00%
Patients with More than one race3 9.32% 3.70% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 11.86% 21.60% 11.11%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.24% 1.23% 0.00%
Unreported/Refused to Report Race and Ethnicity 6.78% 9.88% 0.00%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 20.00%
1 to 24 Hours 40.00%
More Than 24 Hours 20.00%
N/A 20.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 20.00%
Vaccine confidence 20.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 40.00%
None 20.00%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 102.00%
Average Percent of Health Center Visits Conducted Virtually 28.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 60.00%
Number of Mobile Van Sites 2
Number of Pop-up Clinics 6
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 60.00%
None 40.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 20.00%
Therapy administration/onsite logistics 0.00%
Other 20.00%
None 60.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021